Repigment, Reframe, Restore: JAK Inhibition A New Era for Vitiligo 🎯

🎨 Repigment, Reframe, Restore: A New Era for Vitiligo Vitiligo is far more than a cosmetic condition. In two phase 3 Viti-Up trials, oral upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48 weeks. 💊 But here is the deeper lesson: better pigmentation ≠ complete patient benefit. Only 13–15% reported their vitiligo as "a lot less" or "no longer" noticeable. 👁️ The future of vitiligo care must measure not only pigment, but also dignity, mental health, long-term safety and access. 🧠❤️ #Vitiligo #Dermatology #JAKInhibitors #MedicalPodcasts